Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: What about willfulness damages from 2011 until they purchase a license

"I'm just not sure what happens at this pont in regards to willfullness with respect to non-HTC entities because of the NDCA/ITC split decision. It's too far outside of my experience."

Understood.....Thank you.

Maybe Agility has indeed, a sophisticated, Legal plan going forward which can be legally implemented and recognized by the Court as a valid, legally recognized approach, previously implemented by other firms and not New Legal Theory. TBD.

Specifically, regarding pursuing Non-HTC entities and potential Willfullness aspects Post Oct 5 going forward, PTSC Shareholders may, may have to wait until the Next SHM for Agility/Flowers to provide guidance and a Road Plan going forward, illustrating how PTSC can monetize the NDOC Verdict to the fullest extant possible within the confines of the Law.

Virt

Share
New Message
Please login to post a reply